74 related articles for article (PubMed ID: 10365120)
21. Does immediate operation for symptomatic non-ruptured abdominal aortic aneurysm compromise outcome?
Tambyraja AL; Raza Z; Stuart WP; Murie JA; Chalmers RT
Eur J Vasc Endovasc Surg; 2004 Nov; 28(5):543-6. PubMed ID: 15465377
[TBL] [Abstract][Full Text] [Related]
22. Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response.
Shteinberg D; Halak M; Shapiro S; Kinarty A; Sobol E; Lahat N; Karmeli R
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):462-5. PubMed ID: 11112466
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology, aetiology, risk of rupture and treatment of abdominal aortic aneurysms: does sex matter?
Grootenboer N; Bosch JL; Hendriks JM; van Sambeek MR
Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):278-84. PubMed ID: 19540779
[TBL] [Abstract][Full Text] [Related]
24. Management of abdominal aortic aneurysm and concomitant malignant disease.
Peeters B; Moreels N; Vermassen F; van Herzeele I
J Cardiovasc Surg (Torino); 2019 Aug; 60(4):468-475. PubMed ID: 30916530
[TBL] [Abstract][Full Text] [Related]
25. Diversity in renal function monitoring and dose modifications during treatment for childhood cancer: a call for standardization.
Blufpand HN; Hes N; Bökenkamp A; van de Wetering MD; Kaspers GJ
Pediatr Blood Cancer; 2014 Feb; 61(2):337-44. PubMed ID: 23907811
[TBL] [Abstract][Full Text] [Related]
26. Aging: an important risk factor in chemotherapy-associated vascular diseases.
Roselli M; Guadagni F; Ferroni P
Expert Rev Anticancer Ther; 2013 Aug; 13(8):899-901. PubMed ID: 23984891
[No Abstract] [Full Text] [Related]
27. [Reduction and withdrawal of chemotherapy].
Yamaguchi S; Kato S
Nihon Rinsho; 2015 Feb; 73 Suppl 2():79-84. PubMed ID: 25831728
[No Abstract] [Full Text] [Related]
28. Effects of chemotherapy on the kidney.
Cobos E; Hall RR
Semin Nephrol; 1993 May; 13(3):297-305. PubMed ID: 8321929
[No Abstract] [Full Text] [Related]
29. Vascular toxicity associated with chemotherapy and hormonotherapy.
Doll DC; Yarbro JW
Curr Opin Oncol; 1994 Jul; 6(4):345-50. PubMed ID: 7803535
[TBL] [Abstract][Full Text] [Related]
30. [Points of management for elderly patients in chemotherapy].
Komine K; Ishioka C
Nihon Rinsho; 2015 Feb; 73 Suppl 2():51-6. PubMed ID: 25831723
[No Abstract] [Full Text] [Related]
31. [Safety management in the outpatient chemotherapy unit].
Yanagihara K; Matsumoto R; Kurahashi M
Nihon Rinsho; 2015 Feb; 73 Suppl 2():63-6. PubMed ID: 25831725
[No Abstract] [Full Text] [Related]
32. [2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity].
Bönner F; Fenk R; Kochanek M; Pfister R
Dtsch Med Wochenschr; 2017 Dec; 142(24):1826-1830. PubMed ID: 29207427
[No Abstract] [Full Text] [Related]
33. Management of AAA and Concomitant Intra-Abdominal Malignancy: the Jury is Still Out.
Boyle JR
Eur J Vasc Endovasc Surg; 2016 Dec; 52(6):757. PubMed ID: 27756529
[No Abstract] [Full Text] [Related]
34. [Behavior of various classes of plasma immunoglobulins during antiblastic therapy].
Brigato G; Ilacqua N; Fantucci D; Palazzi G; Pisano G
Minerva Ginecol; 1975 Mar; 27(3):187-8. PubMed ID: 1128836
[No Abstract] [Full Text] [Related]
35. It seemed like a good idea at the time.
Adamson PC
Pediatr Blood Cancer; 2014 Feb; 61(2):187-8. PubMed ID: 24115462
[No Abstract] [Full Text] [Related]
36. [Etiopathogenetic and therapeutic problems of superficial thrombophlebitis during antiblastic therapy].
Picardi N; Pasta V; Merlino G
Ann Ital Chir; 1981; 53(6):671-9. PubMed ID: 7347504
[No Abstract] [Full Text] [Related]
37. [SURGERY AND ANTIBLASTIC CHEMOTHERAPY IN TREATMENT OF MALIGNANTNEOPLASMS].
MALAN E
Minerva Med; 1965 Jun; 56():1968-75. PubMed ID: 14325054
[No Abstract] [Full Text] [Related]
38. [FUNDAMENTAL PRINCIPLES OF ANTIBLASTIC CHEMOTHERAPY].
ESTEVEZ RA
Sem Med; 1964 Mar; 124():399-401. PubMed ID: 14153138
[No Abstract] [Full Text] [Related]
39. [General mechanism of action and side-effects of antiblastic chemotherapy].
BASERGA A
Arcisp S Anna Ferrara; 1963; 16():171-5. PubMed ID: 13969823
[No Abstract] [Full Text] [Related]
40. CRITICAL REVIEW OF PROBLEMS OF CHEMOTHERAPY.
BOYLAND E
Proc R Soc Med; 1963 Aug; 56(8):640-2. PubMed ID: 14052444
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
